share_log

CORRECTION: On Thursday March 21, 2024 ARS Pharmaceuticals Reported Q4 EPS $(0.07) Beats $(0.14) Estimate

Moomoo 24/7 ·  Mar 22 16:15

ARS Pharmaceuticals (NASDAQ:SPRY) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.14) by 50 percent.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment